Injective ETF Showdown: Is the SEC Finally Ready to Greenlight Staked INJ?
The crypto world holds its breath as Injective's staked ETF filing lands on the SEC's desk—will regulators blink, or bury it in paperwork purgatory?
Staking meets traditional finance
Injective's proposal dares to bridge DeFi yield mechanics with Wall Street's favorite wrapper. The SEC hates innovation unless it's wrapped in 200 pages of legalese—so this could get interesting.
Regulatory roulette
Gary Gensler's team has rejected every crypto ETF that didn't come with a Bitcoin ticker. But staking rewards might be the Trojan horse that finally cracks the fortress.
Meanwhile, TradFi brokers are already practicing how to pronounce 'INJ' between golf swings.
